PLN 122.5
(-2.78%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 152.85 Million PLN | 37.79% |
2022 | 118.93 Million PLN | -15.2% |
2021 | 133.52 Million PLN | 76.21% |
2020 | 84.75 Million PLN | 32.64% |
2019 | 57.5 Million PLN | 21.98% |
2018 | 45.87 Million PLN | 19.19% |
2017 | 39.2 Million PLN | 30.42% |
2016 | 29.9 Million PLN | -13.34% |
2015 | 34.13 Million PLN | 172.76% |
2014 | 14.41 Million PLN | -21.22% |
2013 | 16.9 Million PLN | 65.14% |
2012 | 20.91 Million PLN | 16.73% |
2011 | 8.4 Million PLN | -28.67% |
2010 | 8.71 Million PLN | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 40.7 Million PLN | -6.66% |
2024 Q2 | 42.53 Million PLN | 9.59% |
2023 Q3 | 43.64 Million PLN | 26.73% |
2023 Q1 | 32.87 Million PLN | 7.63% |
2023 FY | - PLN | 37.79% |
2023 Q4 | 45.32 Million PLN | 3.84% |
2023 Q2 | 34.43 Million PLN | 4.75% |
2022 Q3 | 33.98 Million PLN | 78.55% |
2022 FY | - PLN | -15.2% |
2022 Q1 | 26.5 Million PLN | -44.38% |
2022 Q2 | 19.03 Million PLN | -28.2% |
2022 Q4 | 30.54 Million PLN | -10.11% |
2021 FY | - PLN | 76.21% |
2021 Q1 | 31.47 Million PLN | -11.78% |
2021 Q2 | 36.16 Million PLN | 14.9% |
2021 Q3 | 22.77 Million PLN | -37.01% |
2021 Q4 | 47.65 Million PLN | 109.21% |
2020 Q4 | 35.67 Million PLN | 40.6% |
2020 FY | - PLN | 32.64% |
2020 Q3 | 25.37 Million PLN | 424.23% |
2020 Q2 | 4.84 Million PLN | -52.68% |
2020 Q1 | 10.22 Million PLN | -34.78% |
2019 Q4 | 15.68 Million PLN | 6.75% |
2019 Q3 | 14.69 Million PLN | 5.8% |
2019 Q2 | 13.88 Million PLN | 7.18% |
2019 Q1 | 12.95 Million PLN | -17.25% |
2019 FY | - PLN | 21.98% |
2018 FY | - PLN | 19.19% |
2018 Q2 | 9.86 Million PLN | 9.09% |
2018 Q4 | 15.65 Million PLN | 26.71% |
2018 Q3 | 12.35 Million PLN | 25.31% |
2018 Q1 | 9.03 Million PLN | -40.71% |
2017 Q4 | 15.24 Million PLN | 62.16% |
2017 Q3 | 9.4 Million PLN | 46.84% |
2017 FY | - PLN | 30.42% |
2017 Q1 | 8.36 Million PLN | -24.97% |
2017 Q2 | 6.4 Million PLN | -23.43% |
2016 Q3 | 6.05 Million PLN | -18.63% |
2016 Q2 | 7.44 Million PLN | 26.9% |
2016 Q4 | 11.14 Million PLN | 83.93% |
2016 FY | - PLN | -13.34% |
2016 Q1 | 5.86 Million PLN | -42.33% |
2015 Q4 | 10.17 Million PLN | 42.6% |
2015 Q1 | 7.07 Million PLN | 488.28% |
2015 Q2 | 8.84 Million PLN | 24.96% |
2015 Q3 | 7.13 Million PLN | -19.34% |
2015 FY | - PLN | 172.76% |
2014 Q3 | 2.98 Million PLN | -11.37% |
2014 FY | - PLN | -21.22% |
2014 Q4 | 1.2 Million PLN | -59.69% |
2014 Q2 | 3.36 Million PLN | -36.42% |
2014 Q1 | 5.29 Million PLN | 14.1% |
2013 Q2 | 3.75 Million PLN | -0.54% |
2013 Q4 | 4.64 Million PLN | 14.93% |
2013 Q3 | 4.04 Million PLN | 7.71% |
2013 FY | - PLN | 65.14% |
2013 Q1 | 3.77 Million PLN | -21.35% |
2012 Q4 | 4.79 Million PLN | 486.94% |
2012 Q1 | 4.53 Million PLN | 1311.82% |
2012 Q2 | 2.6 Million PLN | -42.65% |
2012 Q3 | 816.9 Thousand PLN | -68.61% |
2012 FY | - PLN | 16.73% |
2011 Q3 | 130.9 Thousand PLN | 0.0% |
2011 FY | - PLN | -28.67% |
2011 Q4 | 321.41 Thousand PLN | 145.54% |
2010 FY | - PLN | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
BioMaxima S.A. | 3.28 Million PLN | -4554.421% |
Scope Fluidics S.A. | -17.24 Million PLN | 986.248% |
Selvita S.A. | 125.61 Million PLN | -21.684% |